Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 505432, 6 pages
http://dx.doi.org/10.5402/2012/505432
Clinical Study

In Crohn's Disease, Anti-TNF- 𝜢 Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells

1Immune Response Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Haartmaninkatu 8, 00290 Helsinki, Finland
2Division of Gastroenterology, Department of Medicine, Helsinki University Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
3Children's Hospital, University of Helsinki, Stenbäckinkatu 11, 00290 Helsinki, Finland

Received 27 March 2012; Accepted 18 April 2012

Academic Editors: Y. Araki, J. M. Pajares, and C.-T. Shun

Copyright © 2012 Veera Hölttä et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Veera Hölttä, Taina Sipponen, Mia Westerholm-Ormio, et al., “In Crohn's Disease, Anti-TNF- Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells,” ISRN Gastroenterology, vol. 2012, Article ID 505432, 6 pages, 2012. https://doi.org/10.5402/2012/505432.